This study demonstrated the over-expression of Nectin-2 in breast and ovarian cancer tissues and showed that the anti-Nectin-2 human mAb Y-443 exerts an in vivo anti-tumor effect on OV-90 and MDA-MB-231 cells via ADCC as the main mechanism of action. Here, NECTIN2 is linked to ovarian cancer.